Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab in Relapsed NLPHL
NCT01187303Phase 2Completed
- Sponsor
- University of Cologne
- Start
- May 2011
- Primary completion
- Nov 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), sponsored by University of Cologne. Started May 2011; status: completed.
02
Drugs
ofatumumab
03
Conditions
nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)
Beyond the preview
Go deeper on NCT01187303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187303.